Literature DB >> 11070462

Inhibitory effect of N-acetylcysteine on adherence of Streptococcus pneumoniae and Haemophilus influenzae to human oropharyngeal epithelial cells in vitro.

G C Riise1, I Qvarfordt, S Larsson, V Eliasson, B A Andersson.   

Abstract

BACKGROUND: Bacterial adherence to mucosal and epithelial cell structures is of importance for the persistence of bacteria in the airways. Cigarette smoking and chronic bronchitis are associated with increased bacterial adherence. N-Acetylcysteine (NAC) medication reduces the number of infectious exacerbations in patients with chronic bronchitis, and NAC medication has been associated with low intrabronchial bacterial numbers.
OBJECTIVE: We investigated whether NAC influences bacterial adherence as a possible mechanism behind its clinical effects.
METHODS: Highly adhering test strains of Streptococcus pneumoniae and Haemophilus influenzae were used to investigate the influence of four pharmacological compounds on adherence to oropharyngeal epithelial cells in vitro. Adhesion assays were performed both during short-term exposure to, as well as after long-time incubation with, NAC, lidocaine, hydrocortisone and terbutaline at concentrations not inhibiting bacterial growth.
RESULTS: Only NAC showed a significant inhibitory effect on adhesion of H. influenzae during short-term incubation. After long-term incubation, both NAC and hydrocortisone inhibited bacterial adhesion for both strains in a dose-dependent manner. When NAC's effect on three different strains of S. pneumoniae and four strains of H. influenzae was studied, inhibition of bacterial adhesion was found for three strains of each species.
CONCLUSIONS: NAC lowers bacterial adhesion in vitro to oropharyngeal epithelial cells in doses equivalent to that is being used clinically. This effect might be a contributory mechanism behind the reduction of infectious exacerbations in chronic bronchitis patients. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11070462     DOI: 10.1159/000067473

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  20 in total

1.  Preventing exacerbations of chronic bronchitis and COPD.

Authors:  A Ekberg-Jansson; S Larsson; C G Löfdahl
Journal:  BMJ       Date:  2001-05-26

Review 2.  Role of biofilm in children with recurrent upper respiratory tract infections.

Authors:  E Nazzari; S Torretta; L Pignataro; P Marchisio; S Esposito
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-10-16       Impact factor: 3.267

3.  N-Acetyl-l-Cysteine and Cysteamine as New Strategies against Mixed Biofilms of Nonencapsulated Streptococcus pneumoniae and Nontypeable Haemophilus influenzae.

Authors:  Mirian Domenech; Ernesto García
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

4.  N-acetylcysteine, a novel treatment for Helicobacter pylori infection.

Authors:  Hien Quoc Huynh; Richard T L Couper; Cuong D Tran; Lynette Moore; Richard Kelso; Ross N Butler
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

5.  N-acetyl-L-cysteine affects growth, extracellular polysaccharide production, and bacterial biofilm formation on solid surfaces.

Authors:  Ann-Cathrin Olofsson; Malte Hermansson; Hans Elwing
Journal:  Appl Environ Microbiol       Date:  2003-08       Impact factor: 4.792

6.  Update on pharmaceutical and minimally invasive management strategies for chronic obstructive pulmonary disease.

Authors:  Rokhsara Rafii; Timothy E Albertson; Samuel Louie; Andrew L Chan
Journal:  Pulm Med       Date:  2011-04-20

7.  N-acetylcysteine in agriculture, a novel use for an old molecule: focus on controlling the plant-pathogen Xylella fastidiosa.

Authors:  Lígia S Muranaka; Thais E Giorgiano; Marco A Takita; Moacir R Forim; Luis F C Silva; Helvécio D Coletta-Filho; Marcos A Machado; Alessandra A de Souza
Journal:  PLoS One       Date:  2013-08-23       Impact factor: 3.240

Review 8.  Biofilm formation in Streptococcus pneumoniae.

Authors:  Mirian Domenech; Ernesto García; Miriam Moscoso
Journal:  Microb Biotechnol       Date:  2011-09-09       Impact factor: 5.813

Review 9.  Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease.

Authors:  Hoi Nam Tse; Cee Zhung Steven Tseng
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-08-06

Review 10.  The role for N-acetylcysteine in the management of COPD.

Authors:  P N R Dekhuijzen; W J C van Beurden
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.